A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma. The study was published today in the Journal of Clinical Oncology.
- Read more about Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplants
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/antiviral-t-cells-safe-and-effective-for-treating-debilitating-complication-common-after-stem-cell-transplants
No comments:
Post a Comment